Multilevel approach to boost follow-up colonoscopy after abnormal FIT
Official title: PROACT: Promoting Follow-Up of Abnormal Colorectal Cancer Screening Tests Through Multilevel Interventions
Run by Fred Hutchinson Cancer Center · NCT06822530 · Data updated 2026-11-12
This trial tests a multilevel program to help people with abnormal FIT results complete a follow-up colonoscopy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 75 Years |
| Sex | All |
| Enrollment | 682 (estimated) |
| Sponsor | Fred Hutchinson Cancer Center Academic / other |
| Locations | 1 site (Seattle, Washington) |
| Status | Recruiting |
| Started | December 16, 2025 |
| Main results expected | January 31, 2030 |
| Study ends | January 31, 2030 |
| Registry record updated | June 22, 2026 |
| Trial ID | NCT06822530 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 45-75 who had an abnormal FIT, are enrolled at the specified UW/Fred Hutch clinics, and have not yet had a colonoscopy.
✕Probably not a fit
Patients unable to access rideshare services or who do not respond to educational materials may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests a multilevel intervention aimed at increasing follow-up colonoscopy after an abnormal FIT result. Participants are adults 45 to 75 receiving care at specified UW/Fred Hutch clinics and who have had an abnormal FIT but not yet completed colonoscopy. They are randomized to usual care with a CRC screening navigator versus usual care plus a patient-facing video and transportation assistance to address common barriers. The intervention includes a patient navigator, an educational video delivered via QR code or link, and rideshare transportation after colonoscopy, with 18 months of follow-up after the intervention. Outcomes focus on the rate of completed colonoscopy and related process measures across groups.
Why it matters
Potential benefit: If successful, the program could increase timely follow-up colonoscopies after abnormal FITs, potentially improving CRC detection.
How similar studies have gone: Prior studies with navigator support and patient education have shown improvements in follow-up after abnormal CRC screening tests, but the added transport and quick-response video are being tested here.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * PATIENTS: Age \>= 45 years old and =\< 75 years old * PATIENTS: Receives care at an Harborview Medical Center (HMC) or University of Washington-Kent-Des Moines (UW-KDM) or University of Washington- Federal Way (UW-Federal Way) primary care clinic * PATIENTS: \>= 1 month from documented abnormal FIT result * PATIENTS: Has not received a colonoscopy between the abnormal FIT and enrollment * CLINIC STAFF: HMC, UW-Federal Way, or UW-KDM physician or staff member who provides primary care or gastroenterology care * CLINIC STAFF: Staff in the Fred Hutchinson (Fred Hutch)/UW Medicine Population Health Program that provide colorectal cancer screening and navigation
Where it's running
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States Recruiting
Study contacts
- Principal investigator: Rachel B. Issaka, MD, MAS — Fred Hutch/University of Washington Cancer Consortium
- Study coordinator: Rachel B. Issaka, MD, MAS
- Email: rissaka@fredhutch.org
- Phone: 206-667-1447
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exercise after pelvic radiation to see if it lowers colorectal cancer risk
This study tests whether regular walking therapy after pelvic radiation for prostate cancer can influence markers of colorectal cancer in colon tissue and blood.
-
Irreversible Electroporation for Recurrent Pelvic Tumors
This study tests whether using irreversible electroporation (IRE) is safe and helps control recurrent pelvic tumors in adults who can’t have other local treatments.
-
Smart Symptom Tracking with ALEX for GI Health in Young Adults
This trial tests whether the Smart Symptom Tracking ALEX app can better track GI symptoms in young adults (18–44) compared with standard paper logs.
-
Culturally adapted online genetic counseling and testing education for African American cancer survivors
We will test a culturally adapted online genetic counseling program to see if it increases genetic counseling and genetic testing among African American breast, prostate, and colorectal cancer survivors.
-
Zanidatamab given before surgery for HER2-positive colon or rectal cancer
This tests whether giving zanidatamab before surgery helps adults with HER2-positive, RAS‑wildtype colon or rectal cancer who are planned for curative treatment.
-
In-home cancer treatment with remote specialist support for patients in the Florida Panhandle
This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.